Skip to main navigation
Skip to search
Skip to main content
HSC Home
Home
Research units
Profiles
Publications
Sponsored Projects
Core Facilities
Search by expertise, name or affiliation
Endocytic Selective Toxicity of Rhodamine 6G nanoGUMBOS in Breast Cancer Cells
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Endocytic Selective Toxicity of Rhodamine 6G nanoGUMBOS in Breast Cancer Cells'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Breast Cancer Cells
100%
Selective Toxicity
100%
Rhodamine 6G (Rh6G)
100%
Endocytic
100%
NanoGUMBOS
100%
Cancer Cells
42%
Nanomaterials
42%
In Cancer
28%
Endocytic Internalization
28%
Therapeutic Properties
28%
Nanoparticles
14%
Therapeutic Effect
14%
Potential Therapeutics
14%
Cellular Uptake
14%
Dissociation
14%
Tumor Volume
14%
Endocytosis
14%
Mouse Xenograft Model
14%
No Toxicity
14%
Material-based
14%
Clathrin-mediated Endocytosis
14%
Endosomal
14%
Selective Cytotoxicity
14%
In Vivo Investigation
14%
Organic Salt
14%
Endocytosis Inhibitor
14%
Selectivity Mechanism
14%
Selective Behavior
14%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Breast Cancer
100%
Rhodamine 6G
100%
Nanomaterial
100%
Neoplasm
33%
Nanoparticle
33%
Therapeutic Effect
33%
Clathrin
33%
Cytotoxicity
33%